1 month AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied Setback Investor's Business Daily
AbbVie stock popped Friday after an analyst upgraded it on the remaining opportunity for its Cerevel takeover despite a huge misstep.
The post AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied Setback appeared first on Investor's Business D…
AbbVie (ABBV) · Bristol · Business
X